Open AccessEzetimibe in Combination With a Statin Does Not Reduce All-Cause Mortality
Author(s) -
Patel
Publication year - 2013
Publication title -
journal of clinical medicine research
Language(s) - English
Resource type - Journals
eISSN - 1918-3011
pISSN - 1918-3003
DOI - 10.4021/jocmr1371w
Subject(s) - ezetimibe , medicine , statin , population , univariate analysis , logistic regression , cohort , multivariate analysis , environmental health
Although the ezetimibe-statin combination has been shown to reduce LDL cholesterol by 12% compared to a statin alone, its effect on hard clinical endpoints such as mortality is less certain. Prior trials evaluated this combination in highly select population groups, but impact on all- cause mortality in the general population has not been reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom